-
Coherus BioSciences (NASDAQ:CHRS) Earns Buy Rating from HC Wainwright
Source: Buzz FX / 23 Jan 2025 07:21:16 America/Chicago
Coherus BioSciences (NASDAQ:CHRS) Earns Buy Rating from HC Wainwright Written by MarketBeat January 23, 2025 Share Link copied to clipboard. Coherus BioSciences ( NASDAQ:CHRS - Get Free Report ) 's stock had its "buy" rating restated by ana
Read more...